In his third year as the CEO of Johnson & Johnson, Joaquin Duato received an overall compensation package worth $24.3 million. | In his third year as the CEO of Johnson & Johnson, Joaquin Duato ...
Johnson & Johnson MedTech (NYSE: JNJ) announced new regulatory nods for multiple orthopedic technology offerings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback